Acadia Healthcare Company Inc at JPMorgan Healthcare Conference Transcript
Hello, everyone. Thank you for joining us this afternoon. It's my pleasure to introduce Chris Hunter and Todd Young, the Acadia Healthcare CEO and CFO. We're going to have a presentation and maybe a little time for Q&A at the end. Chris?
Thank you, Harry. Good afternoon, everyone. Thanks for joining us. We're going to spend today covering a few key themes. First, we're going to provide an overview of the company, and then we'll get into some of the progress that we've made in 2025, as well as some of the challenges.
And finally, we'll talk about some of the key puts and takes as we look further into 2026.
Before we get into that, I just wanted to flag that we did reiterate our 2025 guidance this morning. We continue to expect revenue of $3.28 billion to $3.3 billion, adjusted EBITDA of $601 million to $611 million, and adjusted EPS of $1.94 to -- $1.94 to $2.04. As usual, we will provide fourth quarter
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
